Literature DB >> 2784043

Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy.

A M Goffinet1, A G De Volder, C Gillain, D Rectem, A Bol, C Michel, M Cogneau, D Labar, C Laterre.   

Abstract

A regional analysis of cerebral glucose metabolism was carried out in 9 patients with progressive supranuclear palsy by using positron emission tomography with fluorodeoxyglucose as the tracer. A consistent metabolic map of frontal hypometabolism was found in 7 patients. Brain metabolism was normal in 1 subject and diffusely decreased in another. In the 7 patients with selective hypofrontality, motor and premotor areas were severely hypometabolic, while heteromodal association cortex and paralimbic regions were comparatively less affected. Although this pattern of frontal alterations, probably due to disconnection, appeared consistent with the clinical features of the disease, it proved difficult to correlate the metabolic maps with neuropsychological disturbances.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784043     DOI: 10.1002/ana.410250205

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  18 in total

1.  Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography.

Authors:  H Karbe; M Grond; M Huber; K Herholz; J Kessler; W D Heiss
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

Review 2.  PET: its clinical role in neurology.

Authors:  D Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

3.  A case of progressive supranuclear palsy with widespread senile plaques.

Authors:  S Sasaki; S Maruyama; C Toyoda
Journal:  J Neurol       Date:  1991-09       Impact factor: 4.849

Review 4.  The neurodegenerative mitochondriopathies.

Authors:  Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

5.  A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism.

Authors:  Jean-Claude Baron
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-15       Impact factor: 9.236

6.  Progressive neuropsychological and extrapyramidal deterioration resembling progressive supranuclear palsy: is aphasia relevant for correct diagnosis?

Authors:  E Capitani; M Laiacona; R Barbarotto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

7.  Initial letter and semantic category fluency in Alzheimer's disease, Huntington's disease, and progressive supranuclear palsy.

Authors:  A Rosser; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

8.  Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction.

Authors:  T W Robbins; M James; A M Owen; K W Lange; A J Lees; P N Leigh; C D Marsden; N P Quinn; B A Summers
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-01       Impact factor: 10.154

9.  Neuronal ceroid-lipofuscinosis: preferential metabolic alterations in thalamus and posterior association cortex demonstrated by PET.

Authors:  A G De Volder; S Cirelli; T de Barsy; J M Brucher; A Bol; C Michel; A M Goffinet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-12       Impact factor: 10.154

10.  Category-specific deficits for grammatical classes of words: evidence for possible anatomical correlates.

Authors:  A Daniele; M C Silveri; L Giustolisi; C Gainotti
Journal:  Ital J Neurol Sci       Date:  1993-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.